NCT03970655View on ClinicalTrials.gov

Functional Endoscopic Sinus Surgery Study

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2026

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
DRUG

Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1

Group 1 will receive 4 ml of 0.5% Bupivacaine or Ropivacaine with epinephrine in the LEFT pterygopalatine fossa

DRUG

Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 2

Group 2 will receive 4 ml of 0.5% Bupivacaine or Ropivacaine with epinephrine in the RIGHT pterygopalatine fossa

Trial Locations (1)

32610

RECRUITING

UF Health of University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER